Proteases

Comprehensive Biotechnology, Second Edition

Volumn 3, Issue , 2011, Pages 571-582

  Ward, O P ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

Author keywords

Aspergillus; Bacillus; Chymosin; Detergent enzymes; Protease; Protease applications; Protease inhibitors; Proteases in organic synthesis; Subtilisin; Therapeutic proteases

Indexed keywords

EID: 85012844614     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00222-1     Document Type: Chapter

References (21)

1. Adams J., Palombella V.J., Sausville E.A., et al. Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Research 1999, 59:2615-2622.
2. Dolly J.O., Aoki K.R. The structure and action of different botulinum toxins. European Journal of Neurology 2006, 13(supplement 4):1-9.
3. Fujinami S., Fugisawa M. Industrial applications of alkaliphiles and their enzymes - past, present and future. Environmental Technology 2010, 31:845-857.
4. Harrington D.J. Bacterial collagenases and collagen-degrading enzymes and their potential in human disease. Infection and Immunity 1996, 64:1885-1891.
5. Kuchner O., Arnold F.H. Directed evolution of enzyme catalysts. TibTech 1997, 15:523-529.
6. Kumar C.G., Takegi H. Microbial alkaline proteases: From a bioindustrial viewpoint. Biotechnology Advances 1999, 17:561-594.
7. Kunst F., Ogasawara N., Moszer I., et al. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature 1997, 390:249-256.
8. Levin J. Protease inhibitors and prevention of cross resistance. Aids Treatment News 1995, October 6.
9. Lodish H., Berk A., Matsudaira P., et al. Molecular Cell Biology 2004, W.H. Freeman, New York, pp. 66-72. 5th edn.
10. Stereoselective Biocatalysis 2000, Dekker, New York. R.N. Patel (Ed.).
11. Biocatalysis in the Pharmaceutical and Biotechnology Industries 2006, CRC, Boca Raton. R.N. Patel (Ed.).
12. Rao M.B., Tanksale A.M., Ghatge M.S., Deshpande V.V. Molecular and biotechnological aspects of microbial proteases. Microbiology and Molecular Biology Reviews 1998, 62:597-635.
13. Schallmey M., Singh A., Ward O.P. Developments in the use of Bacillus species in industrial production. Canadian Journal of Microbiology 2004, 50:1-17.
14. Sumantha A., Larroche C., Pandey A. Microbiology and industrial biotechnology of food-grade proteases: A perspective. Food Technology and Biotechnology 2006, 44:211-220.
15. Takami H., Nakasone K., Takaki Y., et al. Complete genome sequence of the alkaliphilic bacterium Bacillus halodurans and genomic sequence comparison with Bacillus subtilis. Nucleic Acids Research 2000, 28:4317-4331.
16. Vivien D., Buisson A. Serine protease inhibitors: Novel therapeutic targets for stroke. Journal of Cerebral Blood Flow and Metabolism 2000, 20:755-764.
17. Ward O.P. Proteinases. Microbial Enzymes and Biotechnology 1983, 251-317. Applied Science, London. W.M. Fogarty (Ed.).
18. Ward O.P. Proteolytic Enzymes. Comprehensive Biotechnology 1985, vol. 3:789-818. Pergamon, London. M. Moo-Young (Ed.).
19. Ward O.P., Qin Q.M., Dhanjoon J., et al. Physiology and Biotechnology of Aspergillus. Advances in Applied Microbiology 2006, 58:1-75.
20. Ward O.P., Rao M.B., Kulkarni A. Proteases. Encyclopedia of Microbiology 2009, vol. 1:495-511. Elsevier, Amsterdam. 3rd edn. M. Schaechter (Ed.).
21. Yanes O., Villanueva J., Querol E., Aviles F.X. Inhibitors in the medical leech Hirudo medicinalis monitored by intensity fading MALDI-TOF MS http://www.mcponline.org/content/4/10/1602.abstract.